Does anyone know if we have wait for approvals from anyone before beginning the clinical trials. I believe an assumed the sites were already chosen with the return response from the FDA on Pre-IND response.
Should response be construed as “acceptance “ that the clinical trial proceed without additional approvals?
Hoping for a quick results from the hospitals and doctors reviewing the identified patients.
News 
Market Data 
Discover 
AI
